Rare diseases
Investigational molecules
Locations
Back to Germany39 clinical trials in Kempten (Allgau), Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Extensive studies focusing on non-small cell lung cancer (NSCLC) treatments, including trials for both early-stage and metastatic disease. Research encompasses novel combination therapies and targeted treatments for specific genetic mutations.
Evaluating innovative drug combinations and immunotherapy options for improved patient outcomes.
Comprehensive research on HER2-positive and triple-negative breast cancer, investigating new therapeutic approaches and treatment combinations for various stages of the disease.
Focus on personalized treatment strategies and molecular-based approaches.
Innovative trials examining treatments for gastroesophageal junction adenocarcinoma and colorectal cancers, with emphasis on surgical and non-surgical approaches.
Exploring combined modality treatments including chemotherapy and radiotherapy options.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
